Paper17545302
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.
Nakagawa T. Am J Physiol Renal Physiol, 2007. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Papers, record 17545302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Neuropathies | Major topic |
| Endothelium, Vascular | Major topic |
| Nitric Oxide | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mice, Knockout | |
| Neovascularization, Pathologic | |
| Nitric Oxide Synthase Type III |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DK-52121 | NIDDK NIH HHS | United States | R01DK052121 | PubMed and NIH |
Source NIH RePORTER
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41942617 | The evaluation of an HIV-PrEP drug on the vascular health outcomes in a diet-induced prediabetes condition rat model. | Sci Rep | 2026 | https://conductscience.org/library/papers/41942617 | PubMed |
| 41872605 | The endothelium response to kidney injury. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/41872605 | PubMed |
| 41258550 | Binge drinking as a potential cardiometabolic risk factor during adolescence in rats: novel protective antinitrosative mechanism of folic acid via caveolin-1. | Hypertens Res | 2026 | https://conductscience.org/library/papers/41258550 | PubMed |
| 41145714 | Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF. | Hypertens Res | 2026 | https://conductscience.org/library/papers/41145714 | PubMed |
| 40935879 | Mechanisms of diabetic kidney disease and established and emerging treatments. | Nat Rev Endocrinol | 2026 | https://conductscience.org/library/papers/40935879 | PubMed |
| 40534661 | Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40534661 | PubMed |
| 39434726 | Impact of diabetes mellitus and hypertension on renal function during first-line targeted therapy for metastatic renal cell carcinoma: a retrospective multicenter study. | Transl Androl Urol | 2024 | https://conductscience.org/library/papers/39434726 | PubMed |
| 39382984 | Targeting Krüppel-Like Factor 2 as a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/39382984 | PubMed |
| 38981608 | Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease. | Am J Physiol Cell Physiol | 2024 | https://conductscience.org/library/papers/38981608 | PubMed |
| 37900932 | A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib. | Case Rep Nephrol Dial | 2023 | https://conductscience.org/library/papers/37900932 | PubMed |
| 36986570 | Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986570 | PubMed |
| 36718295 | Blood Glucose, HbA1c Level, and its Correlation with VEGF-A (+405G/C) Polymorphism as Biomarker Predicts the Risk of Retinopathy and Nephropathy in Type 2 Diabetic Patients. | Rep Biochem Mol Biol | 2022 | https://conductscience.org/library/papers/36718295 | PubMed |
| 36364178 | Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes. | Molecules | 2022 | https://conductscience.org/library/papers/36364178 | PubMed |
| 35618410 | Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases. | Ren Fail | 2022 | https://conductscience.org/library/papers/35618410 | PubMed |
| 34781638 | Fructose in the kidney: from physiology to pathology. | Kidney Res Clin Pract | 2021 | https://conductscience.org/library/papers/34781638 | PubMed |
| 34489711 | Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34489711 | PubMed |
| 34220855 | Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease. | Front Immunol | 2021 | https://conductscience.org/library/papers/34220855 | PubMed |
| 33737643 | A dose-escalating toxicology study of the candidate biologic ELP-VEGF. | Sci Rep | 2021 | https://conductscience.org/library/papers/33737643 | PubMed |
| 33655322 | Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review). | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33655322 | PubMed |
| 32253274 | Fructose Production and Metabolism in the Kidney. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32253274 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17545302
GET https://conductscience.org/api/papers/v1/17545302/cited_by?page=2